Vassiliki Aroniadou-Anderjaska Selected Research

Kainic Acid (Kainate)

2/2011

The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vassiliki Aroniadou-Anderjaska Research Topics

Disease

20	Status Epilepticus (Complex Partial Status Epilepticus) 10/2023 - 02/2008
20	Seizures (Absence Seizure) 09/2023 - 08/2009
3	Mental Disorders (Mental Disorder) 02/2014 - 10/2004
3	Epilepsy (Aura) 02/2011 - 02/2008
2	Respiratory Insufficiency (Respiratory Failure) 10/2023 - 01/2013
2	Body Weight (Weight, Body) 10/2018 - 11/2017
1	Neuroinflammatory Diseases 10/2023
1	Inflammation (Inflammations) 10/2023
1	Atrophy 01/2018
1	Anxiety Disorders (Anxiety Disorder) 09/2014
1	Alzheimer Disease (Alzheimer's Disease) 11/2013
1	Schizophrenia (Dementia Praecox) 11/2013
1	Pain (Aches) 02/2011
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2008
1	Stroke (Strokes) 02/2008
1	Temporal Lobe Epilepsy 02/2008

Drug/Important Bio-Agent (IBA)

19	Nerve AgentsIBA 09/2023 - 09/2009
13	SomanIBA 07/2022 - 09/2010
10	tezampanelIBA 09/2023 - 02/2011
7	Anticonvulsants (Antiepileptic Drugs)IBA 09/2023 - 08/2009
6	AcetylcholinesteraseIBA 10/2023 - 09/2013
6	Midazolam (Versed)FDA LinkGeneric 09/2023 - 01/2020
6	Diazepam (Valium)FDA LinkGeneric 12/2020 - 01/2010
3	Cholinergic Agents (Cholinergics)IBA 10/2023 - 09/2014
3	caramiphenIBA 09/2023 - 10/2018
3	Kainic Acid Receptors (Kainate Receptor)IBA 11/2014 - 10/2004
3	AcidsIBA 01/2013 - 08/2009
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2023 - 01/2020
2	Muscarinic M1 ReceptorIBA 10/2023 - 01/2017
2	Neuroprotective AgentsIBA 09/2023 - 12/2020
2	BenzodiazepinesIBA 12/2020 - 01/2018
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2020 - 02/2011
2	OrganophosphatesIBA 01/2020 - 01/2017
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2020 - 01/2017
2	Atropine FDA LinkGeneric 04/2015 - 01/2013
2	Carboxylic AcidsIBA 01/2013 - 02/2011
2	1H-tetrazole (tetrazole)IBA 01/2013 - 02/2011
2	GABA-A Receptors (GABA(A) Receptor)IBA 03/2011 - 01/2010
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2020
1	Muscarinic AntagonistsIBA 11/2020
1	N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamideIBA 01/2017
1	willardiineIBA 11/2014
1	1- (2- amino- 2- carboxyethyl)- 3- (2- carboxybenzyl)pyrimidine- 2,4- dioneIBA 11/2014
1	Acid Sensing Ion ChannelsIBA 02/2014
1	Nicotine FDA Link 11/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 11/2013
1	OximesIBA 01/2013
1	asoxime chloride (H16)IBA 01/2013
1	AMPA Receptors (AMPA Receptor)IBA 01/2013
1	ConvulsantsIBA 03/2011
1	cyclonite (RDX)IBA 03/2011
1	Kainic Acid (Kainate)IBA 02/2011
1	fluoro-jade CIBA 09/2010
1	sulfamic acid (ammonium sulfamate)IBA 08/2009
1	Topiramate (Topamax)FDA LinkGeneric 08/2009
1	Gluk1 kainate receptorIBA 08/2009

Therapy/Procedure

1	Emergency Treatment 02/2011
1	Drug Therapy (Chemotherapy) 02/2008